Evidence map›Paper›PMID 40503036›Full record

ArticleOncology letters2025

Clinical and prognostic characteristics of metastatic colorectal cancer with minor

Yoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, Yumi Amano, Ryota Mori, Masatoshi Kitakaze, Toshinori Sueda, Tomoyuki Otsuka, Minako Nishio, Mikiya Ishihara and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yoshiki KojitaniDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Daisuke SakaiDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Takatsugu OgataDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Yumi AmanoDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Ryota MoriDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Masatoshi KitakazeDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Toshinori SuedaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Tomoyuki OtsukaDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Minako NishioDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Mikiya IshiharaDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Yoshinori KagawaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Junichi NishimuraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Naotoshi SugimotoDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Toshinari YagiDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Masayuki TakedaDepartment of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Masayoshi YasuiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.
Toshihiro KudoDepartment of Medical Oncology, Osaka International Cancer Institute, Osaka, Osaka 541-8567, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic colorectal cancer (mCRC) presents notable therapeutic challenges. Rat sarcoma virus (

Indexed as

CRCminor RAS mutationsNRASprognostic characteristicsRAS mutations

Identifiers

PMID40503036
PMCPMC12150841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.